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SUMMARY
The basic-helix-loop-helix (bHLH) transcription fac-
tor Hand2 plays critical roles during cardiac mor-
phogenesis via expression and function within
myocardial, neural crest, and epicardial cell popula-
tions. Here, we show that Hand2 plays two essential
Notch-dependent roles within the endocardium.
Endocardial ablation of Hand2 results in failure to
develop a patent tricuspid valve, intraventricular
septum defects, and hypotrabeculated ventricles,
which collectively resemble the human congenital
defect tricuspid atresia. We show endocardial
Hand2 to be an integral downstream component
of a Notch endocardium-to-myocardium signaling
pathway and a direct transcriptional regulator of
Neuregulin1. Additionally, Hand2 participates in
endocardium-to-endocardium-based cell signaling,
with Hand2 mutant hearts displaying an increased
density of coronary lumens. Molecular analyses
further reveal dysregulation of several crucial com-
ponents of Vegf signaling, including VegfA, VegfR2,
Nrp1, and VegfR3. Thus, Hand2 functions as a crucial
downstream transcriptional effector of endocardial
Notch signaling during both cardiogenesis and coro-
nary vasculogenesis.
INTRODUCTION
In the primitive heart, communication between the endocar-
dium, which is the endothelium-like tissue that lines the heart,
and the myocardium, which is the muscular heart tissue, is
essential for processes central to normal cardiac morphogen-
esis, including trabeculation, chamber septation, and coronary
vasculogenesis (Bruneau, 2003; Brutsaert, 2003). The trans-
membrane receptor Notch1 is integral to this communica-
tion, as endocardial Notch activates endocardial EphrinB2,
which through unknown mechanisms activates expression
of the secreted factor Neurgulin1 (Nrg1). Nrg1 initiates the
trabeculation process, and Notch signaling subsequently acti-
vates expression of Bmp10 (Chen et al., 2004) through a
separate pathway (Grego-Bessa et al., 2007). Bmp10 expres-
sion stimulates proper proliferation of trabecular, and possibly
septal, myocardium. Disruption of Notch-mediated endocar-
dial-myocardial communication results in congenital heart de-
fects (CHDs), which are the most frequent human develop-
mental anomalies (Hoffman, 1995).
Tricuspid atresia (TA) is a CHD characterized by the lack of a
direct connection between the right atria (RA) and the right
ventricle (RV), requiring both ventricular (VSD) and atrial (ASD)
septal defects for embryonic survival (Anderson et al., 1979).
Conditional ablation of the basic-helix-loop-helix (bHLH) factor
Hand2 within the second heart field (SHF) viaMef2c-Cre results
in TA (Tsuchihashi et al., 2011).Mef2c-Cre marks a pool of SHF
progenitor cells that contribute to both the myocardium and
endocardium (Tsuchihashi et al., 2011; Verzi et al., 2005), and
SHF ablation of Hand2 causes TA via unknown mechanisms.
As cardiomyocyte-specific ablation of Hand2 does not result in
TA (Tsuchihashi et al., 2011), we hypothesized that loss of
Hand2 function within the endocardium is causative of TA.
Indeed, our data reveal that either endothelial or endocardial-
specific deletion of Hand2 (H2CKO) using either Tie2-Cre or
Nfatc1Cre, respectively, results in TA. These data show that
Hand2 functions downstream of endocardial Notch to mediate
endocardium-to-myocardium signaling via direct transcriptional
regulation of the growth factor Neuregulin1 (Nrg1).
As cardiogenesis proceeds, development of the coronary
vasculature allows for oxygenation of the thickening ventricular
compact zone. Cardiac endothelial cells form the primitive coro-
nary network by angiogenesis (Red-Horse et al., 2010; Wu et al.,
2012), a process that extracardiac models demonstrate to be
Notch dependent. Early embryonic lethality in Notch pathway
mutants has precluded robust analysis of Notch signaling in
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coronary development. Significantly, H2CKO mice survive long
enough to assess the initiation of coronary vascularization, and
our findings indicate that Hand2 modulates coronary develop-
ment through regulation of multiple Vegf signaling components
within the developing heart. Collectively, these data support a
model whereby Notch signaling, via endocardial Hand2 function,
regulates trabeculation, interventricular septum (IVS) formation,
and coronary development.
RESULTS
Endothelial/Endocardial Loss of Hand2 Causes
Trabeculation and Septation Defects that Resemble
Tricuspid Atresia
To test the hypothesis that loss of endocardial Hand2 results in
TA, we intercrossed the endothelial cell-specific Tie2-Cre allele
(Kisanuki et al., 2001) with mice carrying the Hand2 conditional
allele (Hand2fx). Tie2-Cre is expressed in all endothelial cells,
including cells of the ventricular endocardium, coronary endo-
thelium, and atrioventricular cushions (Kisanuki et al., 2001).
Tie2-Cre expression initiates at embryonic day 8.5 (E8.5) (Kisa-
nuki et al., 2001), which is concurrent with the onset of endocar-
dial Hand2 expression (Barnes et al., 2011). Hand2fx/fx;R26RlacZ
females were mated with Tie2-Cre(+);Hand2+/males, and neo-
nates were genotyped. No H2CKOmice were observed (n = 58;
Table S1). We next set up timedmatings and observed that Tie2-
Cre(+);Hand2fx/ embryos die by E14.5 (Table S1). Hand2 dele-
tion within the endocardium is evident by in situ hybridization
(ISH) at E10.5 (Figures 1A and 1B, arrows). Examination of
Tie2-Cre H2CKOs in whole mount (Figures 1D and 1E) and in
section histology (Figures 1G and 1H) reveals hypotrabeculation
(arrow in Figure 1E) and a highly penetrant TA phenotype (Fig-
ure 1H; Table S2) comparable to that reported in the SHF
Mef2c-Cre H2CKOs. At E12.5, we observe hypotrabeculation,
VSDs, rightward septal displacement, and RV hypoplasticity in
Tie2-Cre H2CKO hearts. Occasionally (20%), we observe a
patent tricuspid valve that makes a direct connection with the
LV, resulting in a double-inlet left ventricle (DILV), a CHD that
functionally resembles TA (Figure 1J, arrow).
To examine atrioventricular (AV) cushion formation, cell den-
sity, and extracellular matrix (ECM) deposition, we stained sec-
tions with Alcian blue. Although comparison of H2CKO cushions
with those of controls revealed no difference in size (Figures 1K
and 1L), there appears to be a cushion-positioning defect
(asterisk in Figure 1L). Despite normal AV cushion ECM deposi-
tion, no direct connection between the RA and RV is detected in
any plane of section, resulting in a single left-sided AV canal in
most H2CKOs, thus meeting the clinical definition of TA (Fig-
ure 1H). However, outflow tract (OFT) morphogenesis occurs
normally in H2CKOs (Figures S1A–S1C).
While we also observe no defects in the yolk sac vasculature
of Tie2-Cre H2CKOs (Figures S1D and S1E), Hand2 may play
critical roles in vascular endothelium that could contribute to
the observed embryonic lethality. Therefore, we used the endo-
cardial-specific Nfatc1Cre allele (Wu et al., 2012) to generate
H2CKOs (Figures 1C, 1F, and 1N). This Nfatc1Cre allele initiates
expression throughout the endocardium at E9.0 (Wu et al.,
2012), as opposed to the Nfatc1enCre allele, which labels only a
subset of valve endothelial cells. Nfatc1Cre H2CKOs also show
dramatic defects in trabeculation, malformed IVS, and atresia
of the tricuspid valve (70%; Figures 1F and 1N). Interestingly,
in some cases, IVS malformations include large protrusions of
myocardium that appear to indicate the formation of multiple
IVSs (Figure 1N, arrows; Table S2). Robust expression of the
septal/compact zone marker Hey2 and the septal marker Irx2
in these large protrusions confirm this observation, while expres-
sion of the trabecular marker Anf is excluded (Figures S2A–S2H).
However, expression of the LV marker Hand1 is not observed
beyond the leftmost septum (Figures S2I and S2J). Tbx5, which
has been suggested to induce the IVS (Takeuchi et al., 2003), is
also unchanged (Figures S2K and S2L). Together, these data
confirm that conditional deletion of Hand2 within the endocar-
dium is critical for normal trabeculation and septation. Given
that these phenotypes are myocardial in nature, this suggests
that endocardial Hand2 plays a crucial role in endocardium-to-
myocardium signaling.
Hand2 Regulates Nrg1 Expression within the
Endocardium
We next investigated changes in gene expression within E10.5
Tie2-Cre H2CKOs using ISH. Expression analysis of Fog2 was
of interest, as Fog2-deficient mice also display TA (Svensson
et al., 2000); however, no change in Fog2 expression was
observed (Figures S3A and S3B). Deletion of Tgfbr2 from the
endothelium results in DILV (Jiao et al., 2006). Analysis of Tgfbr2
expression revealed no differences between H2CKO and con-
trols (Figures S3C and S3D).
It has been directly demonstrated that endocardial Notch
signaling plays an essential role in orchestrating morphogenic
changes within the underlying myocardium, particularly during
the process of trabeculation (Grego-Bessa et al., 2007). There-
fore, we examined Notch pathway gene expression. We first
analyzed expression of the Notch-regulated bHLH transcrip-
tional repressors and potential Hand2 dimer partners, Hey1
and Hey2 (Figures S3E–S3H). Endocardial expression is not
significantly changed. Next, we examined expression of the
direct Notch1 target EphrinB2 (EfnB2; Grego-Bessa et al.,
2007). EfnB2 ISH also shows no change in expression between
H2CKOs and control embryos (Figures 2A–2D). However,
epidermal growth factor family member Neuregulin1 (Nrg1) is
markedly downregulated at E10.5 within the endocardium of
H2CKOs (Figure 2F, arrow in Figure 2H) compared to control em-
bryos (Figure 2E, arrow in Figure 2G). Nrg1 is known to be an
essential mediator of trabeculation in the developing ventricles
and is downregulated in Tie2-Cre Notch1CKOs, and EfnB2 sys-
temic null embryos (Grego-Bessa et al., 2007). The maintenance
of EfnB2 and loss of Nrg1 in H2CKOs suggests that Hand2 acts
downstream of EfnB2, but upstream of Nrg1, representing a
novel step in Notch1 trabeculation and septation signaling.
We next analyzed Bmp10 expression, as myocardially ex-
pressed Bmp10 is crucial for proper trabeculation and is inde-
pendently downstream of Notch1 signaling (Chen et al., 2004;
Grego-Bessa et al., 2007). BMP10 ISH at E10.5 suggests a sub-
tle downregulation in H2CKOs (Figures S3I and S3J) while E12.5
ISH shows a near complete loss of Bmp10-expressing trabec-
ular tissue within the RV but not LV (Figures 2I and 2J, arrows).
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To quantitatively assess Bmp10 expression, we dissected ven-
tricles from E10.5 hearts and isolated RNA for quantitative RT-
PCR (qRT-PCR). As expected, qRT-PCR analysis confirms that
Figure 1. Endocardial Deletion of Hand2
Results in a VSD, Hypotrabeculation, Hypo-
plastic RV, IVS Defects, and TA
(A–C) Hand2 ISH of RV sections from E10.5 con-
trol, Tie2-Cre H2CKO, and Nfatc1Cre H2CKO,
respectively.
(D–F) Whole-mount view of E12.5 control
heart, Tie2-Cre H2CKO, and Nfatc1Cre H2CKO,
respectively.
(G and H) R26RlacZ-stained sections from E12.5
Tie2-Cre(+) control embryo (G) and Tie2-Cre
H2CKO with TA (H).
(I and J) R26RlacZ-stained E12.5 Tie2-Cre(+) con-
trol embryo (I) and Tie2-Cre H2CKO with DILV (J).
(K–N) R26RlacZ-stained sections from E12.5
Nfatc1Cre control embryo (M) and Nfatc1Cre
H2CKO (N; arrows denote multiple IVSs). Alcian
blue staining of E12.5 Tie2-Cre(+) control AV
cushions (K) and Tie2-Cre H2CKO (L). Asterisk
denotes abnormalities in AV cushion shape and
position.
SAVC, superior atrioventricular cushion; IAVC,
inferior atrioventricular cushion; tv, tricuspid valve;
mv, mitral valve. Scale bars represent 100 mm in in
(A)–(C) and 250 mm in in (G)–(N).
both Hand2 and Nrg1 are significantly
downregulated in H2CKOs (Figure 2K)
but Bmp10 myocardial expression is
not altered (Figure 2K). Thus, the reduc-
tion of Bmp10 within the RV of E12.5
H2CKOs reflects the absence of RV tra-
beculation, as LV trabeculae express
Bmp10 (Figure 2J).
Endocardial Hand2 Functions
Downstream of Notch1 and the
Direct Notch1 Target EfnB2
Upon interaction with one of its trans-
membrane ligands, the transmembrane
receptor Notch1 is proteolytically cleaved
to generate the Notch1 intracellular
domain (N1ICD). N1ICD translocates to
the nucleus, where it dimerizes with its
partner RBPJk to activate transcription
of target genes. Previous studies have
shown that deletion of Notch1 or RBPJk
results in hypotrabeculation due to loss
of EfnB2 and Nrg1 (Grego-Bessa et al.,
2007). To confirm that Hand2 lies within
the Notch1 signaling pathway, we as-
sayed Hand2 expression in E9.5
RBPJk/ embryos. Whole mount ana-
lyses reveal a loss of endocardial Hand2,
while expression within the OFT and
pharyngeal mesenchyme is unaffected
(Figures 3A and 3B). Sectioned embryos confirm a specific
loss of Hand2 within mutant endocardium (Figures 3C and 3D),
definitively establishing Hand2 as a Notch1 signaling effector.
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During trabeculation, N1ICD/RBPJk directly transactivates
EfnB2, which acts through its EphB2/EphB4 tyrosine kinase
receptors to upregulate Nrg1 (Grego-Bessa et al., 2007). While
our data clearly show Hand2 to be upstream of Nrg1, it
was not clear if Hand2 lies downstream of EphrinB2 signaling
or if Hand2 represents a parallel EfnB2-independent Notch
signaling pathway. To address this question, we assayed
Hand2 expression in E9.5 Tie2-Cre(+);EfnB2fx/fx embryos (Gerety
and Anderson, 2002). ISH reveals that Hand2 is downregulated
in endocardial cells of Tie2-Cre(+);EfnB2fx/fx embryos (Figure 3F,
arrow), whereas Hand2 expression in pharyngeal mesenchyme
and the proepicardial organ is unaffected when compared to
control hearts (Figure 3E). qRT-PCR analysis at E10.5 confirms
Hand2 downregulation within Tie2-Cre(+);EfnB2fx/fx-isolated
ventricles (Figure 3G). Together, these data show that Hand2
is a Notch-dependent endocardial factor positioned between
EfnB2 and Nrg1.
Hand2 Regulation of Nrg1 Is Direct via Interaction with
the Nrg1 Promoter and Upstream Enhancer Sequences
As Hand2 encodes a transcription factor with a similar expres-
sion profile to Nrg1, we sought to determine if Hand2 regulation
ofNrg1 is direct. An 850 bp region of theNrg1 promoter has been
identified as necessary for high Nrg1 transcriptional activity
in vitro (Frensing et al., 2008). As Hand2 binds the consensus
sequence CANNTG, termed an E-box, or alternatively CGNNTG,
a D-box (Firulli et al., 2007), we searched this aligned promoter
region for these conserved cis elements. Threewere foundwithin
the 500 bp directly upstream of the Nrg1 translation start site
(Figure 4A). To assess Hand2 interaction with this region of the
Nrg1 promoter, we conducted chromatin immunoprecipitation
(ChIP) assays in HeLa cells, employing a Myc-tagged Hand2 co-
transfected with a plasmid encoding an untagged Hand2 dimer-
ization partner, E12. Negative controls included Myc-Hand2 +
E12 immunoprecipitated without aMyc, and pCS2+Myc sam-
ples immunoprecipitated with aMyc. Enrichment of the Nrg1
promoter region was assessed by PCR using primers corre-
sponding to a 103 bp region of the human Nrg1 promoter.
This amplicon shows robust enrichment within Myc-Hand2 +
E12 immunoprecipitated samples (Figure 4B). To confirm that
Hand2-E12 heterodimers are capable of binding the conserved
consensus E/D-box sequences, double-stranded oligos corre-
sponding to these sites were used in electrophoretic mobility
shift assays (EMSA) with in vitro-translated Hand2 and E12
(Figure 4C). Hand2-E12 heterodimers specifically bind oligos
corresponding to sites 1 and 3 (Figures 4D and 4E). No DNA
binding is observed between Hand2-E12 complexes and site
2. To test if Hand2 is capable of transactivating the Nrg1 pro-
moter, Hand2 and E12 expression constructs were transfected
into HeLa cells along with a Nrg1 luciferase reporter containing
the 1,000 bp directly upstream of the murine Nrg1 translation
start site. This region contains multiple transcription start sites
located between 395 and 425 (Frensing et al., 2008). Co-
transfection of Hand2 and E12 resulted in 7-fold reporter activa-
tion. Subsequent assays utilizing truncated promoters (500/
0 bp and 500/250 bp) demonstrated more robust activation
Figure 2. H2CKOs Exhibit Downregulation of Nrg1 and Loss of Bmp10-Expressing Trabecular Myocardium
(A–D) Expression of the Notch1 target EfnB2 is comparable between H2CKOs at E10.5 with controls.
(E–H) Nrg1 expression at E10.5 is markedly decreased in H2CKOs when compared to controls (E–H; arrows in G and H denote endocardium).
(I and J) H2CKOs have less Bmp10-expressing trabecular myocardium in the RV at E12.5 (arrows denote trabecular tissue).
(K) qRT-PCR on isolated ventricles confirms the significant reduction (*p% 0.05) of Nrg1 in E10.5 H2CKOs.
Scale bars represent 200 mm in (A), (B), (E), (F), (I), and (J) and 100 mm in (C), (D), (G), and (H).
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(18- and 16-fold, respectively; Figure 4F). Transactivation data
from the 500 bp promoter revealed that E12 alone is not suffi-
cient for activation, while Hand2 alone results in only modest
(but significant) 3.5-fold transactivation. Consistent with EMSA
results, cotransfection of Hand2 and E12 results in 18-fold
transactivation, while a DNA-binding-deficient Hand2 construct
(Hand2Dbasic) is incapable of Nrg1 transactivation alone or
when cotransfected with E12 (Figure 4G).
Replacement of Hand2 within EfnB2-Deficient
Endocardium Results in an Improvement of Cardiac
Trabeculation
EfnB2mutant embryos display hypotrabeculation accompanied
by loss of Hand2 and Nrg1 expression (Figure 4). Therefore, if
Hand2 is both necessary and sufficient for regulation of Nrg1,
we reasoned that Hand2 replacement in Nfatc1Cre EfnB2CKOs
would restore Nrg1 expression and improve ventricular trabecu-
lation. To test this, we generated the Cre-activatable Hand2
transgene CAG-CAT-Hand2 (CC-H2; Figure S4A). Ectopic
expression of Hand2 in limb mesenchyme results in preaxial
polydactyly (McFadden et al., 2002). As predicted, Prx1-Cre-
mediated activation of CC-H2 within the limb results in polydac-
tyly, indicating that the conditional transgene can be efficiently
and specifically activated (Figure S4B). Similarly, Nfatc1Cre
efficiently activates CC-H2 in the endocardium (Figure S4C).
E13.5 Nfatc1Cre; CC-H2(+) embryos do not display any obvious
cardiac phenotypes (data not shown). Subsequently, CC-
H2(+); EfnB2fx/+ females were then crossed with Nfatc1Cre;
EfnB2fx/+ males to generate Nfatc1Cre; CC-H2(+); EfnB2 CKOs.
CC-H2(); EfnB2 CKOs die by E11.5, with severe pericardial
edema, hemorrhaging, and defects in cardiac looping and
chamber development (Figure 5C). These phenotypes closely
resemble the defects observed in Tie2-Cre EfnB2 CKOs (Gerety
and Anderson, 2002), indicating that while EfnB2 function within
extracardiac vasculature is likely important, loss of endocardial
EfnB2 is sufficient to cause midgestation lethality. Hand2 ISH
at E10.5 confirms robust endocardial Hand2 expression in con-
trols (Figures 5E and 5F) and loss of Hand2 in EfnB2 CKOs (Fig-
ure 5G, arrow). The presence of the CC-H2 allele restores Hand2
expression within the EfnB2 CKOs (Figure 5H, arrow; n = 3).Nrg1
ISH reveals robust expression in controls (Figures 5I and 5J), and
loss of Nrg1 expression in EfnB2 CKOs (Figure 5K, arrow).
CC-H2(+); EfnB2 CKOs display a significant increase in Nrg1
expression (Figure 5L, arrow), while assessment of trabeculation
by Bmp10 ISH reveals a marked improvement in Bmp10-ex-
pressing trabecular myocardium (Figure 5P, arrow) when com-
pared to EfnB2 CKOs lacking the CC-H2 allele (Figure 5O,
arrow). Expression analysis of isolated E10.5 ventricles by
qRT-PCR demonstrates that while still well below control levels,
Nrg1 expression in EfnB2 mutants that carry the CC-H2 allele
(n = 4) is twice as high as in EfnB2 mutants lacking the CC-H2
allele (upregulated 112%). Bmp10 expression is increased by
79% with obvious improvement in trabeculation (Figure 5Q).
Notch-Dependent Hand2 Function Also Regulates
Coronary Angiogenesis
The above analyses demonstrate that endocardial Hand2 plays
a crucial role in myocardial morphogenesis. Myocardial trabe-
culation and compaction are intimately linked to endothelial
cell behavior during development of the coronary vasculature
by a complex signaling network that includes Vegf, Fgf, Tgf-b,
and Notch components (Smart et al., 2009). Furthermore, early
Figure 3. Hand2 Functions Downstream of Notch1 and the Direct Notch1 Target EphrinB2 during Trabeculation
(A and B) Whole-mount Hand2 ISH in wild-type (A) and RBPJk knockout embryos (B). Arrows indicate endocardial Hand2 expression in control (A) and loss of
expression in RBPJk knockouts (B).
(C and D) Hand2 ISH (C) shows robust endocardial Hand2 expression that is downregulated within RBPJk/ endocardium (D).
(E and F) Hand2 ISH (E) revealed a similar downregulation of Hand2 within the endocardium of Tie2-Cre EfnB2CKO hearts (F; arrows denote endocardium).
(G) qRT-PCR on RNA isolated from ventricles confirms significant (*p% 0.05) downregulation of Hand2 and Nrg1 in Tie2-Cre EfnB2CKO hearts.
PM, pharyngeal mesenchyme; PEO, proepicardial organ. Scale bars represent 50 mm in (C) and (D) and 100 mm in (E) and (F).
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embryonic lethality in genetic models of dysfunctional Notch
signaling has precluded an in vivo assessment of the role of
Notch signaling in formation of the coronary arteries. As we
have established Hand2 as an integral component of endocar-
dial Notch signaling, and as coronary endothelium is derived at
least in part from the endocardium (Wu et al., 2012), the survival
of H2CKOs to E14.5 allows us a unique opportunity to assess
Notch function in early coronary development. Analysis of hearts
at E13.5, 1 day after initiation of intramyocardial coronary forma-
tion (Tian et al., 2013), shows that Nfatc1Cre H2CKO hearts (Fig-
ures 6B and 6D, arrows) exhibit an increased density of primitive
coronary vessels when compared to control ventricles (Figures
6A and 6C). Subsequent analyses revealed a comparable
degree of hypervascularization in Tie2-Cre H2CKOs (data not
shown; Table S2). To ascertain the mechanism underlying
this hypervascularization, we analyzed genes associated with
vascular development in E10.5 and E13.5 Nfatc1Cre H2CKO iso-
lated ventricles by qRT-PCR (n = 4; Figures 6E and 6F, respec-
tively). As expected, expression levels of Hand2 and Nrg1 are
down at both time points. Analysis of vascular markers at
E10.5 reveals dysregulation of select components of Vegf
signaling (Figure 6E). VegfR2 is downregulated by 30%, and its
Figure 4. Hand2 Directly Regulates Nrg1
(A) Sequence alignments reveal three Hand2 consensus sites that are highly conserved among mammals.
(B) ChIP of the NRG1 promoter.
(C) In vitro-transcribed and translated Hand2 and E12 used in EMSAs.
(D and E) EMSAs for D-box 1 (D) and E-box 3 (E) show robust and specific binding of Hand2-E12 heterodimers. No binding is observed for site 2.
(F) Luciferase reporter assays with a deletion series of the Nrg1 promoter. Red numbers denote positions of the Hand2 consensus sites; green arrows denote
positions of the transcription start sites; black arrows, location of ChIP primers.
(G) Transactivation of 500 bp Nrg1 promoter reporter (*p% 0.05).
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coreceptor Nrp1 is downregulated by 14%. VegfD, which en-
codes a VegfR3-specific ligand, is downregulated by 25%. By
E13.5, expression levels of VegfR2 and VegfD have recovered
(Figure 6F), whereas Nrp1 remains downregulated. Surprisingly,
expression of VegfA, which encodes the primary Vegf ligand that
regulates vascular development (Ferrara et al., 1996), is upregu-
lated by over 200%. Expression of VegfR3 is upregulated by
120%, and expression of Dll4, which encodes a notch ligand
regulated by VegfRs (Wythe et al., 2013), is upregulated by
approximately 85%. Differential regulation of several additional
key vascular factors was also observed at E13.5. The venous
markers CouptfII and EphB4 are downregulated by 21% and
24% respectively, while the arterial marker EfnB2 is downregu-
lated by 33%. Surprisingly, Sox18 and Lyve1, which encode
Figure 5. Conditional CAG-CAT-Hand2 Transgene Expression in Nfatc1Cre EfnB2 CKOs Partially Improves Trabeculation and Nrg1
Expression
(A–D) Whole-mount images of E10.5 control, CC-H2(+) control, EfnB2 CKO, and CC-H2(+); EfnB2 CKO embryos.
(E–H) Hand2 section ISH. Arrow in (G) indicates loss of Hand2; arrow in (H) indicates restoration of endocardial Hand2 via CC-H2.
(I–L) Nrg1 section ISH. Arrow in (K) indicates loss of Nrg1 in EfnB2 CKOs; arrow in (L) indicates restored Nrg1 expression in EfnB2 CKOs that are also CC-H2(+).
(M–P) Bmp10 section ISH. Arrow in (O) indicates Bmp10-expressing myocardium and lack of trabeculation; arrow in (P) indicates restoration of Bmp10-ex-
pressing trabeculations.
(Q) qRT-PCR analysis of isolated E10.5 ventricles. Asterisks denote significant difference (p% 0.05). CC-H2, CAG-CAT-Hand2.
Scale bars in (E)–(P) represent 100 mm.
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factors typically associated with endothelium of the lymphatic
system, were upregulated by 45% and 73% respectively. To
determine what cardiac cell populations were upregulating
Lyve-1, we conducted Lyve-1 immunostaining at E10.5 (Figures
6G and 6H) and E13.5 (Figures 6I–6N) in control and H2CKO
hearts. Sections from E13.5 hearts were costained with VegfR2
to mark cardiac endothelium (see Table S3 for a glossary of
terminology pertaining to endothelial cell populations). E10.5
immunostaining reveals that Lyve-1 is expressed robustly within
endocardium of both control and H2CKO hearts. In contrast, by
E13.5, Lyve-1 immunostaining in control hearts is restricted to a
population of peripheral cardiac macrophages (Figure 6I; Pinto
et al., 2012), whereas robust Lyve-1 immunostaining persists in
the ventricular endocardium of H2CKOs (Figures 6J and 6L).
However, while Lyve-1 still robustly marks H2CKO ventricular
endocardium (Figure 6N, white arrow), Lyve-1 expression does
not mark the expanded coronary endothelium of H2CKOs (Fig-
ure 6N, yellow arrow).
As previously mentioned, qRT-PCR demonstrates differential
expression of several Vegf signaling components. We therefore
investigated, using ChIP, ChIP sequencing (ChIP-seq), EMSA,
and luciferase reporter assays, the possibility that Hand2 directly
regulates at least a subset of these components (Figure 7A).
Given that our results establish Hand2 as a downstream effector
of Notch signaling, and Notch also regulates expression of
VegfRs within endothelial cells (Herbert and Stainier, 2011), we
first addressed the possibility that Hand2 directly regulates
VegfR3 expression. Using the previously described HeLa ChIP
samples, we show that immunoprecipitation of Hand2-Myc/
E12-transfected cell lysates results in selective enrichment of a
region within the VegfR3 promoter that has been previously re-
ported to have regulatory activity (Figure 7B; Shawber et al.,
Figure 6. Hand2 Controls Coronary Development and Endocardial Maturation via Regulation of Vegf Signaling
(A and B) R26RlacZ-stained E13.5 hearts.
(C and D) LV outer curvature. Nfatc1Cre H2CKOs display hypervascularization (arrows in D).
(E and F) qRT-PCR analysis of E10.5 and E13.5 gene expression (n = 4) in Nfatc1Cre H2CKOs (asterisks denote significant difference, p% 0.05).
(G and H) Lyve-1 immunostaining in E10.5 Control and Tie2-Cre H2CKO hearts.
(I–N) Lyve-1 immunostaining in E13.5 Control and Nfatc1Cre H2CKO hearts. In E13.5 control hearts Lyve-1 expression is restricted to endothelial lymphatic
precursors (K), while H2CKOs continue to express Lvye-1 within ventricular endocardium (L, white arrow). Persistent Lyve-1 expression marks ventricular
endocardium (N, white arrow), but not coronary endothelium (N, yellow arrow). Dotted lines denote the border between compact and trabecular myocardium.
Scale bars represent 250 mm in (A) and (B), 100 mm in (C) and (D), 200 mm in (G) and (H), 250 mm in (I) and (J), and 50 mm in (K)–(N).
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2007). Furthermore, by EMSA, we show that Hand2 E12 hetero-
dimers specifically bind an oligo corresponding to one of the two
E-boxes within this human promoter region (Figure 7C), which
consists of the 500 bp upstream of the VegfR3 translation start
site. Finally, a luciferase reporter containing the homologous
500 bp mouse promoter was significantly repressed by Hand2
E12 heterodimers (50% repression; p % 0.05; Figure 7D).
Collectively, these data indicate that Hand2may directly repress
VegfR3 expression within cardiac endothelium.
To detect additional Hand2 targets, we utilized a Hand2 ChIP-
seq data set that was generated for an alternate study (Oster-
walder et al., 2014). This ChIP-seq data set employed a
Hand2-3xFLAG knockin allele. E10.5 Hand2-expressing tissues,
including the heart, were collected and used for an immunopre-
cipitation of Hand2-bound regions of genomic DNA. This data
set was cross-referenced with our H2CKO gene expression
data, where in addition to increased VegfR3, we observed
decreased expression of the VegfR2 cofactor Nrp1. Analysis of
Hand2-3xFLAG ChIP-seq data revealed a region of high enrich-
ment 356 kb upstream of the Nrp1 coding region (Figure 7E; Ta-
ble S4). An approximately 3 kb region containing this potential
enhancer was cloned upstream of a luciferase reporter driven
by the thymidine kinase (TK) minimal promoter. When cotrans-
fected into HeLa cells with Hand2 and E12, a significant 5.2-
fold transactivation was observed (Figure 7F). Analysis of VegfR3
and Nrp1 expression by ISH reveals expression within cardiac
endothelium (Figures S5A andS5B), although differential expres-
sion between controls and H2CKOs is not detectable by this
nonquantitative assay.
Given that VegfA is upregulated by over 200% in E13.5
H2CKOs, we analyzed the Hand2-3xFLAG ChIP-seq data set
for evidence of direct regulation. No prominent peaks were
Figure 7. Hand2 Regulates Vegf Signaling
(A) Differentially expressed genes that were analyzed for direct regulation by Hand2.
(B) ChIP of a region within the 500 bp VegfR3 promoter.
(C) EMSA demonstrates Hand2-E12 heterodimers specifically bind an oligo corresponding to an E-box within the ChIP amplicon of the VegfR3 promoter. Black
arrow indicates E12 homodimer binding, red arrow indicates Hand2-E12 heterodimer binding, and asterisk indicates nonspecific binding.
(D) Hand2-E12 heterodimers repress significantly (p% 0.05) a luciferase reporter containing the 500 bp VegfR3 promoter.
(E) Hand2-3xFLAG ChIP-seq demonstrates a prominent region of enrichment approximately 356 kb upstream of the Nrp1 coding region.
(F) A luciferase reporter containing this potential enhancer region is significantly (p% 0.05) transactivated 5-fold by H2-E12 heterodimers.
(G) ISH demonstrates strongmyocardial expression of VegfAwithin the compact zone of control E13.5 hearts. Red dots denote the border between compact and
trabecular myocardium.
(H) In H2CKOs, the distinction between VegfA expression levels in compact versus trabecular myocardium is more poorly defined.
Scale bars in (G) and (H) represent 100 mm.
Cell Reports 9, 2071–2083, December 24, 2014 ª2014 The Authors 2079
detected within the VegfA locus. Indeed, ISH demonstrates that
VegfA expression is not detectable within endocardium. How-
ever, VegfA is strongly expressedwithin themyocardial compact
zone, with low levels of expression observed within trabeculae
(Figure 7G). In H2CKOs, the difference in expression levels
between compact and trabecular myocardium is visibly less
distinct, with high VegfA expressing regions appearing to extend
beyond the compact zone (Figure 7H).
DISCUSSION
Loss of Hand2 within the SHF cardiac progenitors that give rise
to both endocardial and myocardial lineages has been associ-
ated with TA. In this study, we show that loss of Hand2 specif-
ically in the endocardium, a cell population in which robust
Hand2 expression has previously gone uninvestigated, can
cell-autonomously generate TA. These results underscore the
importance of effective endocardial-myocardial signaling during
early cardiac morphogenesis. Mechanistically, our data show
that endocardial Hand2 sits downstream of Notch1 and EfnB2
and is itself directly upstream of Nrg1, being necessary and
sufficient for Nrg1 expression in vivo. Notch signaling is a well-
established component of endocardium-to-myocardium com-
munication. Hand2 endocardial roles include regulation of
trabeculation, positioning of the IVS, and IVS morphogenesis.
Indeed, endocardial H2CKOs present multiple septa that are
marked by Irx2 and compact zone/septal marker Hey2, while
excluding trabecular marker Anf (Figure S2). These ectopic
right-sided septa do not express Hand1 or Tbx5 at their left
side base (Figures S2I–S2L), suggesting that these septa form
via a noncanonical mechanism from RV cardiomyocytes.
These data demonstrate that endocardial Hand2 regulates the
specification of trabecular and septal myocardium from primitive
myocardium. Given the striking similarities between the cardiac
defects of EfnB2 knockouts (Figures 3F and 3G), which do not
express Nrg1, and the reported phenotypes of Nrg1 knockouts
(Kramer et al., 1996), the most logical conclusion is that loss of
Nrg1 expression is the root cause of the hypotrabeculation,
septal, and TA phenotypes observed in H2CKOs.
We show that trabeculation and Nrg1 expression within EfnB2
CKO mice is improved by Hand2 replacement via the CC-H2
transgene (Figure 5). Hand2 is necessary for normal expression
of Nrg1 (Figure 2), and we demonstrate that Hand2 is sufficient
for partial restoration of Nrg1 expression levels in EfnB2 CKOs.
While trabeculation is markedly improved in CC-H2(+) EfnB2
CKOs, these embryos still display hallmarks of cardiovascular
failure such as pericardial edema and hemorrhage. The incom-
plete restoration of normal cardiac phenotype is not surprising
given that restoration of Nrg1 expression is incomplete, and
EfnB2 signaling likely has a much broader range of endocardial
downstream targets then just Hand2. Our observation that
37% of Nrg1 expression remains in Tie2-Cre H2CKOs (Fig-
ure 2K) while less than 10% remains in Tie2-Cre EfnB2 CKOs
(Figure 3G) indicates that EfnB2 also influences Nrg1 expression
via Hand2-independent inputs.
While it is clear that endocardial loss of Hand2 impairs the
Notch-dependent processes of trabeculation and septal devel-
opment, it is less clear how this impairment results in TA. It is
possible that multiple morphogenic inputs contribute to the TA
observed in H2CKOs. Previous studies have concluded that TA
occurs when the atrial connection to the AV canal expands right-
ward but the ventricular inner curvature fails to remodel (Kim
et al., 2001). Given the dramatic myocardial defects observed
in H2CKOs, Hand2-dependent remodeling of AV canal myocar-
dium could be involved; however, histological analysis of
H2CKOs suggests a simpler model wherein the septum shifts
rightward in H2CKOs and interferes with development of the
primitive right AV canal, thus resulting in TA. Indeed, we show
that Tie2-Cre H2CKOs have a smaller RV, which is not due to
increased cell death within SHF progenitors, increased cell
deathwithin the RV, or decreased proliferation within the RV (Fig-
ures S6A–S6D). Furthermore, analysis of ventricle areas reveals
that Tie2-Cre H2CKOs have a smaller RV and larger LV but no
change in total area (Figure S6E), thus supporting histological
observations of a rightward-shifted septum. In extreme right-
ward septal shifts, AV cushion maturation is not hindered but
the tricuspid valve forms above the LV, thus resulting in DILV.
Finally, Hand2 ablation within the developing OFT and AV valve
mesenchyme does not alter septation or valve morphogenesis
and does not result in TA (VanDusen et al., 2014). In total, these
data demonstrate a cell-autonomous Hand2-dependent role of
the endocardium in the etiology of TA/DILV.
In addition to the dramatic defects in myocardial morphogen-
esis observed in endocardial H2CKOs, histological analyses at
E13.5 also reveal significant vascular phenotypes. H2CKOs
display precocious and disorganized development of the coro-
nary vascular plexus. Analysis of vascular related gene expres-
sion in E10.5 and E13.5 H2CKOs surprisingly reveals that major
components of cardiac Vegf signaling are dysregulated. VegfR2
and VegfD are downregulated at E10.5, while VegfR3 and VegfA
are significantly upregulated by E13.5. Additionally, VegfR2
coreceptor Nrp1 is downregulated at both E10.5 and E13.5,
while expression of the notch ligand Dll4 is increased at E13.5,
an indication of enhanced Vegf signaling (Figures 6E and 6F).
Furthermore, qRT-PCR and immunostaining reveals elevated
expression of the receptor Lyve-1 within endocardium of E13.5
H2CKOs. Analysis at E10.5 demonstrates that Lyve-1 is initially
expressed throughout the early endocardium and is subse-
quently downregulated as the endocardium matures, such that
by E13.5, expression is no longer detectable within ventricular
endocardium but is observed only within cardiac macrophages.
Given the early endocardial expression of Lyve-1, this persis-
tence withinH2CKOsmost likely represents a defect in endocar-
dial maturation, rather than ectopic activation of the lymphatic
gene program.
Of the genes we observed to be differentially expressed in
E13.5 H2CKOs, both the Dll4 and Nrp1 loci contain prominent
Hand2 Chip-seq peaks (Table S4). Nrp1 encodes an isoform-
specific VegfA receptor that acts in concert with VegfR2. Inter-
estingly, an RNA subtractive hybridization screen previously
identified Nrp1 as being downregulated in Hand2 systemic
null embryos (Yamagishi et al., 2000). Our data indicate that
Nrp1 is an endocardial target of Hand2, although regulation
may also occur in additional tissues where these factors are
coexpressed (Figure S5A). Cotransfection of Hand2 and E12
with a luciferase reporter containing the potential upstream
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enhancer region yielded over 5-fold transactivation, further sup-
porting direct regulation of Nrp1 by Hand2. In contrast, lucif-
erase reporter assays failed to demonstrate Hand2-mediated
repression via the enriched Dll4 upstream region, indicating
that the increased Dll4 expression in H2CKOs may be second-
ary to changes in expression of Vegf receptors, which are
known to regulate Dll4 (Wythe et al., 2013). However, our data
do not rule out Hand2 direct regulation of Dll4 by alternate un-
detected enhancers. Expression of VegfR3 is upregulated in
E13.5 H2CKOs by over 100%. VegfR3 is capable of functioning
as both a homodimer and VegfR3-VegfR2 heterodimer, and
distinct functions have been associated with different inter-
actions (Dixelius et al., 2003). VegfR3 plays crucial roles in
angiogenic sprouting and development of the lymphatic system
(Benedito et al., 2012), and we show that VegfR3 is expressed
within at least a subset of the endocardium (Figure S5B, arrow).
While no high-ranking ChIP-seq peaks were observed within the
VegfR3 locus, cardiac endothelium represents only a small
portion of the total Hand2 expressing tissue that was utilized,
and so sensitivity may be a limiting factor of this assay. Our
HeLa ChIP results indicate that Hand2 interacts with the VegfR3
promoter, while transactivation assays correlate with H2CKO
expression data, indicating that Hand2 may repress VegfR3
transcription. In addition to VegfR3, we observe a 45% increase
in Sox18 expression at E13.5. As Sox18 specifically marks
endothelium of the coronary vasculature at this time point (Fig-
ure S5C), this increase most likely reflects the hypervasculariza-
tion phenotype.
Similar to several extracardiac angiogenic models of Notch
signaling obstruction (Benedito et al., 2012; Tammela et al.,
2008), we show that endocardial Hand2 ablation results in a
hypervascularization phenotype featuring the formation of an
excessive number of new vessels. Furthermore, we show that
this phenotype is accompanied by broad dysregulation of
Vegf signaling. Homeostasis of Vegf signaling is crucial during
embryonic development, as mice heterozygous for a VegfA
null mutation die at E9.5, while an increase in VegfA expression
(3-fold) results in lethality at approximately E13.5 (Miquerol
et al., 2000). In the present study, we demonstrate that
expression of VegfA is expanded in H2CKOs. This could reflect
aberrant specification of trabecular myocardium or secondary
pathological effects of compromised cardiac function. VegfA
is the most differentially regulated gene that we observe, while
VegfR2, VegfR3, and Nrp1 are also dysregulated within
H2CKOs. Given the complex interactions that take place be-
tween these molecules, disrupted receptor stoichiometry and
upregulated VegfA, a growth factor that is well known for its
proangiogenic qualities, most likely account for the observed
coronary phenotype. These data not only provide insight into
a second novel function of Hand2 within the endocardium but
also reveal a wider role of Notch signaling during coronary
vessel development. Coronary heart disease is a major cause
of mortality in developed nations, being responsible for approx-
imately one of every six deaths in the United States (Go et al.,
2013). Consequently, further assessment of Hand2’s regulatory
role in Vegf signaling during coronary vascularization, as well as
potential adult homeostatic roles of Hand2-dependent Notch
signaling, is an interesting avenue of future investigations.
EXPERIMENTAL PROCEDURES
Mice and Genotyping
Tie2-Cre(+) and Nfatc1-Cre(+) mice were crossed with Hand2+/ mice to
generate Tie2-Cre(+);Hand2+/ and Nfatc1-Cre(+);Hand2+/ males. These
males were then crossed with Hand2fx/fx;ROSA26R reporter mice (lacZ or
eYFP) to generate conditional null Hand2 embryos. Tie2-Cre(+) females were
crossed with EfnB2fx/fx males to generate Tie2-Cre(+);EfnB2fx/+ males. These
males were then crossed with EfnB2fx/fx females to generate conditional null
EfnB2 embryos. The cre-activatable transgene CAG-CAT-Hand2 was con-
structed by replacing the Myc-Twist1 cDNA of CAG-CAT-Twist (Connerney
et al., 2006) with the murine Myc-Hand2 cDNA. This construct was used for
microinjection to establish a transgenic line. For genotyping information, see
Supplemental Experimental Procedures. Mouse maintenance and experimen-
tation was performed according to protocols approved by the Indiana Univer-
sity School of Medicine Institutional Animal Care and Use Committee.
Hand2-3xFLAG ChIP-Seq
The Hand2 ChIP-seq data set was generated as part of a previous study using
homozygous Hand2-3xFLAG embryos, which express a 3xFLAG epitope-
tagged Hand2 protein (Osterwalder et al., 2014). Briefly, Hand2-expressing tis-
sues (heart, limbs, and pharyngeal arches) from 150 Hand2-3xFLAG E10.5
embryos were dissected and pooled. Samples were crosslinked in 1% form-
aldehyde for 5 min and ChIP was performed using FLAG antibodies (Sigma
F1804). ChIP-seq reads were mapped to the mouse genome (NCBI37/mm9)
and peaks were detected using MACS (version 1.3.7.1) for the HAND2-
3xFLAG and input control samples. Statistically validated peaks were sorted
according to fold enrichment and number of reads.
Section RNA In Situ Hybridization
Antisense digoxigenin labeled riboprobes were transcribed with T7, SP6, or T3
(Roche). Section ISH was performed as previously described (Vincentz et al.,
2008). The cDNA for a Fog2 riboprobe was kindly supplied by Eric Svensson,
Tbx20 by Simon Conway, Anf and Irx2 by Vincent Christoffels, TgfbR2 by Hen-
ry Sucov, and EfnB2 by Hai Wang. All data reflect assessment in n R 3 em-
bryos for ISH and immunostaining and nR 4 for qRT-PCR analyses.
Quantitative RT-PCR
Total RNAwas isolated fromE10.5 or E13.5 ventricles using the High Pure RNA
Isolation Kit (Roche). This RNA served as a template to generate cDNA using
the Transcriptor First Strand cDNA Synthesis Kit (Roche). For qRT-PCR, cDNA
was amplified using TaqMan Probe-Based Gene Expression Assays (Applied
Biosystems). Relative gene expression was determined after normalization to
GAPDH. The Student’s t test was used to detect significant differences
between sample groups; asterisks denote p values% 0.05. Error bars repre-
sent SE.
EMSAs, Luciferase Assays, and ChIP
Hand2 and E12 were in vitro translated using the Promega Reticulocyte Lysate
System. A total of 5 ml of translated protein was incubated in binding buffer for
30 min at 25C with radiolabeled oligos corresponding to E-boxes and D-
boxes within the Nrg1 and VegfR3 loci (Firulli et al., 2007). Transcription fac-
tor/oligo complexes were run out on a nondenaturing 6% polyacrylamide gel
and assessed on a phosphoimager. For luciferase assays, HeLa cells were
transfected using X-tremeGENE HP (Roche) at a ratio of 3:1 with Nrg1-
500bp+pGL4.10 (luciferase), VegfR3-500bp+pGL4.10 (luciferase), pGL4.73
(SV40-renilla) or pGL4.74 (TK-renilla), Pcs2+Myc-Hand2, Pcs2+Myc-E12,
pcDNA+Myc-DBasic-Hand2 (kindly provided by Eric Olson), or pcDNA3.1
and cultured for 48 hr. After harvest and processing, luciferase and renilla
reporter activity was assessed in equal amounts of cell lysate using Luminos-
kan Ascent software and a ThermoLabsystems luminometer. Luciferase re-
sults were normalized to protein concentration or renilla. Asterisks denote
significant difference from pcDNA control (p value % 0.05); error bars repre-
sent SE. For construction of Nrp1(358/355 kb) and Dll4(23/20 kb) lucif-
erase reporters, genomic regions containing a Hand2-3xFLAG ChIP-seq peak
were PCR amplified and cloned into TK-pGL4.10. For ChIP of the Nrg1 pro-
moter, HeLa cells were again transfected using X-tremeGENE HP at a ratio
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of 3:1. After culturing for 48 hr, cells were processed as previously described
(Barnes et al., 2011). Briefly, equal amounts of sheered chromatin were immu-
noprecipitated overnight at 4Cwith 50 ml of aMyc-conjugated agarose beads
(Sigma) or beadswithout antibody for a negative control. After reversing cross-
links, eluted immunoprecipitated DNA was phenol chloroform extracted, re-
suspended in ddH2O, and used for subsequent PCR reactions. After 37 cycles
of PCR amplification, product was analyzed on an agarose gel. ChIP transfec-
tion constructs included Pcs2+Myc-Hand2, Pcs2+E12, and Pcs2+Myc. See
Supplemental Experimental Procedures for oligo information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and four tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2014.11.021.
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